Correlation Between Aravive and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aravive and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aravive and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aravive and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Aravive and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aravive with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aravive and Reviva Pharmaceuticals.
Diversification Opportunities for Aravive and Reviva Pharmaceuticals
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Aravive and Reviva is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Aravive and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Aravive is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aravive are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Aravive i.e., Aravive and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aravive and Reviva Pharmaceuticals
Given the investment horizon of 90 days Aravive is expected to under-perform the Reviva Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Aravive is 1.59 times less risky than Reviva Pharmaceuticals. The stock trades about -0.83 of its potential returns per unit of risk. The Reviva Pharmaceuticals Holdings is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 487.00 in Reviva Pharmaceuticals Holdings on September 12, 2024 and sell it today you would lose (235.00) from holding Reviva Pharmaceuticals Holdings or give up 48.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 1.14% |
| Values | Daily Returns |
Aravive vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Aravive |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Reviva Pharmaceuticals |
Aravive and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aravive and Reviva Pharmaceuticals
The main advantage of trading using opposite Aravive and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aravive position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.The idea behind Aravive and Reviva Pharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |